Skip to main content
. 2022 May 5;15(5):576. doi: 10.3390/ph15050576

Figure 3.

Figure 3

The dose–response curves for HepG2 cells exposed to 0–200 µM concentrations of the selected number of synthesized compounds. The 20% inhibitory concentration (IC20) and cell viability at the 90% Mtb inhibitory concentration for CAS (MIC90) were extrapolated from the dose–response curve.